Kränke Teresa, Cerpes Urban, Legat Franz, Arbab Emad, Kränke Birger
Universitätsklinik für Dermatologie und Venerologie, Medizinische Universität Graz, Graz, Österreich.
Dermatologie (Heidelb). 2023 Aug;74(8):614-617. doi: 10.1007/s00105-023-05160-3. Epub 2023 May 26.
Starting in 2020, the global health system faced unprecedent challenges due to the coronavirus disease 2019 (COVID-19) pandemic and the consequences are still felt. All the more fascinating and of particular importance for health policy was the development of potent vaccines within about one year by several research groups after the first reports of COVID-19 infections. To date, three types of COVID-19 vaccines are available, i.e., messenger RNA-based vaccines, adenoviral vector vaccines, and inactivated whole-virus vaccines. We report a woman who developed reddish, partially urticarial skin lesions on her right arm and flank shortly after the first dose with the corona vaccination from AstraZeneca/Oxford (ChAdOx1). The lesions were transient, however reoccurred in loco and at other locations over several days. The clinical presentation was unusual and was correctly assigned due to the clinical course.
自2020年起，全球卫生系统因2019冠状病毒病（COVID-19）大流行而面临前所未有的挑战，其影响至今仍在。在首次报告COVID-19感染后的大约一年内，多个研究小组研发出了有效的疫苗，这一进展对卫生政策而言更具吸引力且尤为重要。迄今为止，有三种类型的COVID-19疫苗可供使用，即信使核糖核酸疫苗、腺病毒载体疫苗和灭活全病毒疫苗。我们报告了一名女性，在接种第一剂阿斯利康/牛津大学（ChAdOx1）的新冠疫苗后不久，其右臂和侧腹出现了红色、部分为荨麻疹样的皮肤病变。这些病变是短暂性的，但在数天内于原部位及其他部位再次出现。临床表现不寻常，根据临床病程得以正确诊断。
